The downstream genes of NOX4, such as HER3 or/and NF-κB, may play important roles in the regulation of therapeutic sensitivity, which may provide an experimental basis for further investigation into improving ovarian cancer treatment and prognosis in the future. This evidence concerns the gene NOX4 and ovarian carcinoma.